Nicholas Wealth LLC. Takes Position in Oscar Health, Inc. $OSCR

Nicholas Wealth LLC. acquired a new position in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 106,467 shares of the company’s stock, valued at approximately $2,015,000. Oscar Health accounts for 0.8% of Nicholas Wealth LLC.’s portfolio, making the stock its 28th largest holding.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. LRI Investments LLC boosted its position in shares of Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after buying an additional 975 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after acquiring an additional 1,282 shares during the period. Atlantic Union Bankshares Corp acquired a new position in Oscar Health in the 2nd quarter valued at about $33,000. Jones Financial Companies Lllp lifted its stake in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Finally, Strs Ohio acquired a new position in Oscar Health during the first quarter worth $30,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insiders Place Their Bets

In other Oscar Health news, CFO Richard Scott Blackley sold 25,135 shares of the firm’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $416,989.65. Following the sale, the chief financial officer owned 1,351,034 shares of the company’s stock, valued at $22,413,654.06. This trade represents a 1.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $121,737.42. Following the transaction, the insider owned 172,527 shares in the company, valued at approximately $2,862,222.93. The trade was a 4.08% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 383,307 shares of company stock valued at $5,919,555. Company insiders own 25.11% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on OSCR. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $13.00 to $25.00 in a report on Tuesday, November 25th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. UBS Group raised their price target on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research report on Friday, November 7th. Wall Street Zen downgraded Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. Finally, Barclays upped their target price on shares of Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday, November 10th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $15.57.

Oscar Health Price Performance

NYSE OSCR opened at $14.50 on Wednesday. The stock has a market cap of $3.84 billion, a price-to-earnings ratio of -12.94 and a beta of 1.88. The company has a 50-day moving average price of $16.31 and a two-hundred day moving average price of $17.08. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter last year, the firm posted ($0.22) EPS. Analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.